Catholic HealthClinical Laboratory Technologist-PD- Overnight Catholic HealthClinical Laboratory Technologist-PD- OvernightPort Jefferson, New York$61.12–$66.78 / hourSt. Charles also offers services in general surgery, colon/rectal surgery, bariatric surgery, neurosurgery, ENT, pediatrics, diagnostic imaging, emergency medicine, epilepsy, stroke care, Female Pelvic Floor Disorders Center, and a nationally accredited Sleep Disorders Center. Job Details: The Medical Technologist performs a variety of routine and special clinical laboratory examinations and procedures in the specialties or subspecialties for which they are qualified, which may include, but is not limited to, the Hematology, Chemistry, Blood Bank, Serology, Coagulation, Urinalysis and Phlebotomy departments.
St. Catherine of Siena Medical CenterClinical Laboratory Technologist-PD- Overnight St. Catherine of Siena Medical CenterClinical Laboratory Technologist-PD- OvernightPort Jefferson, NY$61.12–$66.78 / hourSt. Charles also offers services in general surgery, colon/rectal surgery, bariatric surgery, neurosurgery, ENT, pediatrics, diagnostic imaging, emergency medicine, epilepsy, stroke care, Female Pelvic Floor Disorders Center, and a nationally accredited Sleep Disorders Center. The Medical Technologist performs a variety of routine and special clinical laboratory examinations and procedures in the specialties or subspecialties for which they are qualified, which may include, but is not limited to, the Hematology, Chemistry, Blood Bank, Serology, Coagulation, Urinalysis and Phlebotomy departments.
Taylor Strategy PartnersSpecialty Sales Representative – Cardiometabolic Rare Disease Taylor Strategy PartnersSpecialty Sales Representative – Cardiometabolic Rare DiseaseNew Haven, CTRemote$160,000–$180,000 / yearThis is a unique opportunity to play a meaningful role in the launch and growth of our cardiometabolic portfolio, including Plozasiran (siRNA targeting APOC3), developed for patients with rare and high-need cardiovascular conditions such as Familial Chylomicronemia Syndrome (FCS) and Severe Hypertriglyceridemia (SHTG). Arrowhead is leading the field in bringing the promise of RNAi to address diseases outside of the liver, and our clinical pipeline includes disease targets in the liver and lung with a promising pipeline of preclinical candidates.